Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001226410 | SCV001398723 | likely pathogenic | Methylcobalamin deficiency type cblE | 2019-10-08 | criteria provided, single submitter | clinical testing | This variant results in the deletion of exon 8 and part of exon 7 (c.973_1146+462del) of the MTRR gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with MTRR-related conditions. Loss-of-function variants in MTRR are known to be pathogenic (PMID: 15714522). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |